Job/Unit: I31219
/KAP1
Date: 21-11-13 17:13:57
Pages: 15
FULL PAPER
t e m p. , t h e m i x t u r e c o n t a i n e d 1 0 ( 5 % ) , 1 4 ( Ͻ 5 % ) , Reactions of 2(nEt2O) with RPX2
B10H10C2[OPCl(Ph)]2 (35 %), and intermediate products (55%).
2,7-Di(1-methylethyl)-4,5,9,10-bis[1,2-dicarba-closo-dodecaborano-
(12)]-2,7-diphospha-1,3,6,8-tetraoxacyclodecane (11): A suspension
of 2(nEt2O) (0.136 mmol) in [D8]toluene was cooled to –30 °C, and
iPrPCl2 (19.7 mg, 0.017 mL, 0.136 mmol) was injected through a
microsyringe. After stirring the reaction mixture for 2 h at room
temp., insoluble materials were separated by centrifugation, and
the clear liquid was collected. Volatile materials were removed in a
vacuum to give 11 as a white solid together with side products
B10H10C2[OPCl(iPr)]2 (ca. 5 %). The remaining solid of 11 was
washed with [D8]toluene and dried in a vacuum; m.p. 160–170 °C.
Volatile materials were removed in a vacuum, and the residue was
dissolved in CD2Cl2. The remaining mixture contained 10 (Ͻ5%),
14 (Ͻ35%), B10H10C2[OPCl(Ph)]2 (25%), and intermediate prod-
ucts (35%). After 24 h at room temp., the mixture contained 14
(80%), B10H10C2[OPCl(Ph)]2 (15%), and PhPCl2 (Figure 1).
2-Diethylamino-4,5-[1,2-dicarba-closo-dodecaborano(12)]-1,3,2-di-
oxaphospholane (15): Freshly prepared [(1,2-C2B10H10)O2Li2] (2)
(47.9 mg, 0.255 mmol) was dissolved in [D8]toluene (0.5 mL); the
solution was cooled to –30 °C, and Et2NPCl2 (44.3 mg, 0.037 mL,
0.255 mmol) was injected through a microsyringe. After stirring the
reaction mixture for 1 h at room temp., insoluble materials were
separated by centrifugation, and the clear liquid was collected. The
mixture contained 15 (95%) and 17 (Ͻ5%) as a white oil. After
two weeks in [D8]toluene at room temp., the mixture contained 15
(80%) and 17 (20%). Compound 15: 1H{11B} NMR (500.13 MHz,
[D8]toluene, 25 °C): δ = 0.64 [t, 3J(1H,1H) = 7.1 Hz, 6 H, CH3],
2.25 [br. s, 1 H, HB for δ(11B) = –15.8 ppm], 2.37 [br. s, 1 H, HB
for δ(11B) = –13.5 ppm], 2.45 [br. s, 2 H, HB for δ(11B) =
1
Compound 11: H{11B} NMR (500.13 MHz, [D8]toluene, 25 °C):
δ = 0.75 [dd, 3J(31P,1H) = 16.7, 3J(1H,1H) = 7.3 Hz, 12 H, CH3],
1.39 [dsept J(31P,1H) = 3.8, J(1H,1H) = 7.3 Hz, 2 H, PCH], 2.23,
2.26 [br. s, br. s, 2 H, 2 H, HB for δ(11B) = –16.0 ppm], 2.50 [br. s,
8 H, HB for δ(11B) = –10.6, –13.0 ppm], 2.54 [br. s, 4 H, HB for
δ(11B) = –13.0 ppm], 2.65 [br. s, 2 H, HB for δ(11B) = –9.5 ppm],
3.25 [br. s, 2 H, HB for δ(11B) = –13.0 ppm] ppm. 11B{1H} NMR
(160.5 MHz, [D8]toluene, 25 °C): δ = –16.0 (4 B), –13.0 (10 B),
–10.6 (4 B), –9.5 (2 B) ppm. 11B NMR (160.5 MHz, [D8]toluene,
25 °C): δ = –16.0 [d, 1J(11B,1H) = 144 Hz, 4B], –13.0 (d, 10B), –10.6
[d, 1J(11B,1H) = 160 Hz, 4B], –9.5 (d, 2 B) ppm. EI-MS (70 eV) for
2
3
3
3
–11.5 ppm], 2.62 [dq, J(1H,1H) = 7.1, J(31P,1H) = 10.9 Hz, 4 H,
PNCH2], 2.70 [br. s, 3 H, HB for δ(11B) = –15.3, –3.3 ppm], 2.80
[br. s, 2 H, HB for δ(11B) = –13.5 ppm], 2.97 [br. s, 1 H, HB for
δ(11B) = –8.1 ppm] ppm. 11B{1H} NMR (160.5 MHz, [D8]toluene,
25 °C): δ = –15.8 (1 B), –15.3 (2 B), –13.5 (3 B), –11.5 (2 B), –8.1
(1 B), –3.3 (1 B) ppm. 11B NMR (160.5 MHz, [D8]toluene, 25 °C):
δ = –15.8 [d, 1J(11B,1H) = 156 Hz, 1B], –15.3 [d, 1J(11B,1H) =
168 Hz, 2B], –13.5 [d, 1J(11B,1H) = 153 Hz, 3B], –11.5 [d,
1J(11B,1H) = 153 Hz, 2B], –8.1 [d, 1J(11B,1H) = 174 Hz, 1B], –3.3
C10H34O4B20P2 (496.5): m/z (%) = 496 (15) [M+], 453 (40) [M+
–
C3H7], 264 (10) [(M/2 + O)+], 248 (5) [M/2+], 238 (15), 232 (10)
[(M/2 – O)+], 205 (50) [M/2+ – C3H7], 176 (10) [C2H12B10O2], 146
(10), 44 (100) [C3H8].
2,7-Bis(1,1-dimethylethyl)-4,5,9,10-bis[1,2-dicarba-closo-dodeca-
borano(12)]-2,7-diphospha-1,3,6,8-tetraoxacyclodecane (12): A sus-
pension of 2(nEt2O) (0.195 mmol) in [D8]toluene was cooled to
–30 °C, and a solution of tBuPCl2 (0.031 mg, 0.195 mmol) in
[D8]toluene (0.2 mL) was added. After stirring the reaction mixture
for 2 h at room temp., insoluble materials were separated by centri-
fugation, and the clear liquid was collected. The mixture contained
12 (70%), 12Ј (possibly a trimer) (20%), a small amount of un-
identified products (10%) together with tBuPCl2 (31P NMR spec-
troscopy). The solution was heated by 80 °C for 5 d. A white pow-
der that consisted of products 12 was formed that showed rather
low solubility in [D8]toluene. Insoluble solids were separated by
centrifugation, washed with [D8]toluene and dried in a vacuum to
give 12 as a white solid; m.p. 185–195 °C. Compound 12: 1H NMR
(500.13 MHz, [D8]toluene, 25 °C): δ = 0.86 [d, 3J(31P,1H) = 15.1 Hz,
18 H, CH3] ppm. EI-MS (70 eV) for C12H38O4B20P2 (524.6): m/z
(%) = 524 (3) [M+], 467 (100) [M+ – C4H9], 412 (10) [M+ – C4H9 –
C4H8], 351 (3), 205 (5), 57 (100) [C4H9+].
1
[d, J(11B,1H) = 182 Hz, 1B] ppm.
Volatile materials were removed in a vacuum and the residue was
dissolved in CD2Cl2. This solution was left at room temperature
for two weeks, after which transparent colorless crystals of
1·2(HNEt2/HCl) (m.p. 260–270 °C) suitable for X-ray analysis
could be collected. 1H NMR (500.13 MHz, CD2Cl2, 25 °C): δ =
3
1.37 [t, 6 H, CH3, J(1H,1H) = 7.4 Hz], 3.04 (q, 4 H, NCH2), 8.48
(s, 2 H, COH) ppm.
2-Ethoxy-4,5-[1,2-dicarba-closo-dodecaborano(12)]-1,3,2-dioxaphos-
pholane (16): Freshly prepared [(1,2-C2B10H10)O2Li2] (2) (33.2 mg,
0.177 mmol) was dissolved in [D8]toluene (0.5 mL); the solution
was cooled to –30 °C, and EtOPCl2 (26.0 mg, 0.02 mL,
0.177 mmol) was injected through a microsyringe. After stirring the
reaction mixture for 1 h at room temp., insoluble materials were
separated by centrifugation, and the clear liquid was collected. The
mixture contained 16 (80%) and a small amount of unidentified
products. Volatile materials were removed in a vacuum to give the
mixture contained 16 (95%) and 18 (Ͻ5%) as a white oil. Com-
pound 16: 1H{11B} NMR (500.13 MHz, [D8]toluene, 25 °C): δ =
0.68 [t, 3J(1H,1H) = 7.0 Hz, 3 H, CH3], 2.25 [br. s, 1 H, HB for
2,7-Bis(3,5-dimethylphenylmethyl)-4,5,9,10-bis[1,2-dicarba-closo-do-
decaborano(12)]-2,7-diphospha-1,3,6,8-tetraoxacyclodecane (13): A
suspension of 2(nEt2O) (0.21 mmol) in [D8]toluene was cooled to
–30 °C, and (3,5-Me2–C6H3)CH2PBr2 (65.0 mg, 0.21 mmol) was in-
δ(11B) = –14.5 ppm], 2.31 [br. s, 1 H, HB for δ(11B) = –4.8 ppm], jected through a microsyringe. After stirring the reaction mixture
2.35 [br. s, 1 H, HB for δ(11B) = –13.5 ppm], 2.37 [br. s, 2 H, HB for 2 h at room temperature, insoluble materials were separated by
for δ(11B) = –12.4 ppm], 2.67 [br. s, 2 H, HB for δ(11B) =
centrifugation, and the clear liquid was collected. The mixture con-
–15.3 ppm], 2.76 [br. s, 2 H, HB for δ(11B) = –14.5 ppm], 2.85 [br. tained 13 (30%) and unidentified intermediate products (70%), to-
s, 1 H, HB for δ(11B) = –5.5 ppm], 3.27 [dq, 3J(1H,1H) = 7.0 Hz,
3 J(3 1 P,1 H) = 9.9 Hz, 2 H, POCH2 ] ppm. 1 1 B{1 H} NMR
(160.5 MHz, [D8]toluene, 25 °C): δ = –15.3 (2 B), –14.5 (3 B), –13.5
(1 B), –12.4 (2 B), –5.5 (1 B), –4.8 (1 B) ppm. 11 B NMR
(160.5 MHz, [D8]toluene, 25 °C): δ = –15.3 [d, 1J(11B,1H) = 162 Hz,
2B], –14.5 [d, 1J(11B,1H) = 142 Hz, 3B], –13.5 [d, 1J(11B,1H) =
160 Hz, 1B], –12.4 [d, 1J(11B,1H) = 164 Hz, 2B], –5.5 [d, 1J(11B,1H)
= 190 Hz, 1B], –4.8 [d, 1J(11B,1H) = 180 Hz, 1B] ppm. EI-MS
(70 eV) for C4H15O3B10P (250.2): m/z (%) = 250 (55) [M+], 222 (65)
[M+ – C2H4], 175 (100) [C2H11B10O2].
gether with (3,5-Me2–C6H3)CH2PBr2 (from 31P NMR spec-
troscopy). Volatile materials were removed in a vacuum. The resi-
due was dissolved in CD2Cl2, and the solid swimming on top of
the solution was collected and dried in a vacuum to give 13
(30.5 mg, 45%) as a white solid; m.p. 240–245 °C. Transparent col-
orless crystals of 13 for X-ray analysis were grown from the CD2Cl2
solution after one week at –30 °C. 1H{11B} NMR (500.13 MHz,
[D8]toluene, 25 °C): δ = 2.05 (s, 12 H, CH3), 2.23, 2.30 [br. s, br. s,
4 H, 2 H, HB for δ(11B) = –15.9 ppm], 2.42 [br. s, 10 H, HB for
δ(11B) = –11.0, –13.1 ppm], 2.71 [br. s, 2 H, HB for δ(11B) =
Eur. J. Inorg. Chem. 0000, 0–0
11
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim